Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Francesca.Hutton@globaldata.com

  • Home
  • Author: Francesca.Hutton@globaldata.com

Whitbread set to ride out any post-Brexit storm following Q3 results, says GlobalData

Following today’s (17 January 2019) announcement of Whitbread’s Q3 trading results, Nick Wyatt, Head of Tourism at GlobalData, offers his view on the company’s future: “Superficially, Whitbread’s year-to-date numbers look very positive. Year-to-date, year-on-year accommodation revenue growth is an impressive 4.1%, but a deeper look suggests the situation is not quite as rosy as it […]
Read more

The government is risking the tech sector’s future competitiveness over Brexit and needs to take ‘No Deal’ off the table, says GlobalData

Following the outcome of last night’s (15 January 2019) Commons defeat for Theresa May’s Brexit deal, David Bicknell, Principal Analyst for Thematic Research at GlobalData, a leading data and analytics company, offers his view on the impact of Brexit on the tech sector: “The scale of Theresa May’s Commons defeat has left the UK IT […]
Read more

Bristol-Myers Squibb continues to strengthen its immuno-oncology presence with approval for PD-1 inhibitor Opdivo in untreated renal cell carcinoma, says GlobalData

Following the news that the European Commission have approved Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) for previously untreated intermediate- or poor-risk advanced renal cell carcinoma, Chloé Thépaut, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on the company’s position: ‘‘The approval of BMS’ in-house IO combination, […]
Read more

Traditional wealth managers set to lose market share to robo-advisors, says GlobalData

The robo-advisory market is increasing in competition globally, with more start-ups entering the wealth management industry year by year, says GlobalData, a leading data and analytics company. Sergel Woldemicheal, Wealth Management Analyst at GlobalData comments: “In previous years, traditional wealth managers across the globe had a widespread level of agreement that robo-advice would seize market […]
Read more

Cybersecurity concerns will increase in UK wealth management industry in 2019, says GlobalData

In the UK, clients of wealth managers are less apprehensive about data breaches than the majority of their global counterparts. However, examples of data breaches closer to home will influence consumer awareness around the topic and increase concerns, says GlobalData, a leading data and analytics company. GlobalData’s 2018 survey of wealth managers found that, globally, […]
Read more

2019’s top technology, media and telecoms trends

Leading data and analytics company, GlobalData, has revealed its top trends for 2019 across the technology, media and telecoms (TMT) industry. The company’s latest thematic research report, ‘Tech, Media & Telecom Trends 2019’, analyses the major trends impacting companies across 15 TMT sectors. While many of these trends are specific to individual sectors, there are […]
Read more

Bristol-Myers Squibb’s acquisition of Celgene could position the company amongst top five most profitable Pharma giants

Following Bristol-Myers Squibb’s (BMS) announcement on 3 January 2019 that it will acquire Celgene in a cash and stock deal with an equity value of approximately $74bn, Edit Kovalcsik, Managing Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on this significant merger: “Amidst the inevitable transformation of the pharmaceutical industry, […]
Read more

Drug pricing and reimbursement concerns will remain the leading impediment to industry growth in 2019

In 2019, drug pricing pressure from regulators, patients, politicians and payers will remain and aggressive negotiation tactics to drive down drug prices are expected, says GlobalData, a leading data and analytics company. The company’s latest annual outlook report, ‘The State of the Biopharmaceutical Industry – 2019’, reveals that 51% of global industry respondents believe that […]
Read more

5G, e-sports, streaming video and smart homes highlight 2019’s top consumer services trends

Developments across many different and converging service technologies are set to mature and directly impact consumers during 2019, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘2019 Predictions: What to Expect in Consumer Services’ states that the top trends for 2019 include rollouts of new 5G wireless networks, continuing expansion […]
Read more

For Amgen’s infliximab biosimilar to succeed, a sound strategy is needed to differentiate ABP-710 from competitors

Following the announcement of Amgen’s submission of a biologics license application (BLA) for its infliximab biosimilar candidate, ABP-710, Rose Joachim, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on the future prospects of ABP-710, if approved in the US: “Considering that Amgen will not be able to launch its adalimumab […]
Read more

Stelara shows excellent efficacy and safety in Crohn’s but its future in the UC market remains uncertain

Following the announcement of positive results from Janssen’s Phase III open label long- term extension study, which evaluates the efficacy and safety data of Stelara in Crohn’s Disease (CD), Patrick Aiyes, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on Stelara’s future prospects in the Inflammatory Bowel Disease (IBD) market: […]
Read more
1 … 9 10 11 12 13 … 16